RNF8 is a ubiquitin ligase with a FHA domain near its N terminus, and a RING-finger domain at its C terminus, through which it recruits several ubiquitin-conjugating enzymes. In metazoans, only the mitotic checkpoint regulator CHFR shares this domain architecture. Here we show that RNF8 is a nuclear protein that follows a cellcycle-dependent turnover, reaching its highest levels in mitosis, followed by a strong decline in late mitotic stages. Overexpression of RNF8 caused a delay in cytokinesis and the frequent appearance of aberrant mitotic figures. These effects were dependent on the ubiquitin ligase activity of RNF8, since they were significantly attenuated when a RING-finger mutant, inactive as an E3, was overexpressed. Depletion of RNF8 also caused a delay in the exit from the mitotic arrest induced by nocodazole, associated with a reduced turnover of the APC/C substrate cyclin B1. These observations suggest that RNF8 regulates the rate of exit from mitosis and cytokinesis.
Introduction
RING-finger domains are characteristic of a class of ubiquitin ligases and mediate the recruitment of ubiquitin-conjugating enzymes (E2) that ubiquitylate substrate proteins that are tethered to the ligases through interactions with specific recognition domains or subunits (Pickart, 2001; Passmore and Barford, 2004) . The forkhead-associated domain (FHA) is a structural motif that recognizes phosphopeptides in particular sequence contexts (Liao et al., 1999; Durocher et al., 2000) . Although FHA domains were initially identified in transcription factors and in protein kinases, they are also present in other proteins that define or regulate checkpoints (Hofmann and Bucher, 1995) . In eukaryotes, only five proteins bear a FHA domain along with a RING-finger domain, CHFR and RNF8 in metazoans and SpDma1, ScDma1 and ScDma2 in yeasts (Murone and Simanis, 1996; Scolnick and Halazonetis, 2000; Guertin et al., 2002a; Plans et al., 2006) . All these proteins, except for RNF8 that has not been previously studied in the context of the cell cycle, have been shown to regulate mitotic checkpoints. In metazoans, CHFR delays the entry in mitosis in the presence of microtubule poisons by targeting Plk1 and Aurora A for degradation, and hence inhibiting Cdc2 (Kang et al., 2002; Seong et al., 2002; Yu et al., 2005) ; in budding yeasts, ScDma1p and its paralog ScDma2p are involved in proper spindle positioning at mitosis, probably by ensuring the timely activation of the mitotic exit network (MEN) in telophase (Murone and Simanis, 1996; Fraschini et al., 2004) . In fission yeasts, SpDma1p is a regulator of the septation initiation network (SIN) (Guertin et al., 2002b; Moore et al., 2003) .
RNF8 is a ubiquitin ligase that recruits several ubiquitin-conjugating enzymes, including the heterodimeric E2 enzyme UBC13-UEV that promotes the elongation of polyubiquitin chains based on Lys 63 on the ubiquitin polypeptide (Ito et al., 2001; Plans et al., 2006) . RNF8 was previously reported to interact with the nuclear receptor RXRa and to enhance its transcriptional activity (Takano et al., 2004) . In this study, we show that RNF8 has a cell-cycle-dependent turnover and subcellular localization, and we study its activities in the modulation of cell cycle transitions.
Results
Constitutive nuclear localization of RNF8 requires the FHA, RING-finger and coiled-coil domains We had determined previously that staining of HeLa cells with an antibody specific for RNF8 showed a nuclear localization in the majority of cells (Plans et al., 2006) . To study the contribution of each domain of RNF8 to this nuclear localization, HA-tagged fulllength and partial constructs of RNF8 were generated ( Figure 1 ). All constructs were transiently transfected in HeLa cells, their correct expression was confirmed by western blotting (Figure 1a ) and the subcellular localization of RNF8 deletion variants was analysed by immunofluorescence confocal microscopy ( Figure 1c ).
While full-length wild-type RNF8 localized invariably to the nucleus of all transfected cells, the variants lacking the FHA or RING-finger domains, or both, and the C403S mutant with a non-functional RING finger (Ito et al., 2001; Plans et al., 2006) , showed a cytoplasmic localization in addition to a nuclear localization in a large proportion of transfected cells (Figure 1d ). Hence, both the FHA and RING-finger domains contribute to the constitutive nuclear localization of RNF8.
RNF8 has a cell-cycle-dependent turnover
The fact that not all cells were stained for endogenous RNF8, and the similarities of RNF8 with CHFR, whose levels are regulated in different phases of the cell cycle (Chaturvedi et al., 2002) , led us to study whether the expression of RNF8 undergoes variations during the cell division cycle. HeLa cells were synchronized by double thymidine block, released from the block, monitored by flow cytometry for the enrichment of cells in a given phase of the cell cycle ( Figure 2a ) and parallel experiments analysed at 1-h intervals for the expression of endogenous RNF8 by western blotting (Figure 2b ) and immunocytochemistry (Figure 2c ). The specificity of our affinity-purified antibody to RNF8 was tested previously (Plans et al., 2006) , and further confirmed by depletion of experiments with small interfering RNA (siRNA) duplexes specific for RNF8 (see below). Cells arrested at the G 1 -S boundary expressed detectable but relatively low levels of RNF8 that increased in intensity during the S phase (3-4.5 h after release) and continued RNF8 regulates exit from mitosis V Plans et al to rise until the end of the G 2 phase (4.5-5 h), when the signal for RNF8 abruptly decreased at approximately 6 h after release from the thymidine block, with most cells in mitosis ( Figure 2b ). RNF8 showed a nuclear localization in G 1 and S, whereas during prophase, concomitant with nuclear envelope breakdown, RNF8 localized throughout the cell, with a dotted staining pattern (Figure 2c ). In anaphase, the protein was barely detectable and in telophase, coincident with the re-establishment of the nuclear envelope, RNF8 localized again in the nucleus and also with a discrete dotted pattern in the cytoplasm.
In late telophase and during cytokinesis, RNF8 localized intensely in the midbody of the tubulin bridge joining the daughter cells. After mitosis and during early G 1 , expression of RNF8 was reinstated, with a gradual gain in signal upon entering a new cycle (Figure 2c ). RNF8 did not seem to associate with condensed chromosomes at any time during the cell cycle.
Interestingly, while RNF8 was present during S and early G 2 mostly in its usual 55 kDa form, several discrete high-molecular-weight forms of RNF8 increased their levels during a very narrow window in mitosis, before a rapid decline in the levels of the protein (Figure 2b ). This might suggest the occurrence of a covalent modification of RNF8 prior to the degradation of the protein. The ladder-like pattern of discrete bands spaced by 7-8 kDa, or multiples (Figure 2b ) suggests that the covalent modification of RNF8 might be related to ubiquitylation. Treatment of cells with the microtubule depolymerizing drug nocodazole induced higher levels of the 55 kDa form of RNF8, while treatment with taxol resulted in increased levels of the higher molecular weight forms of RNF8 as compared to asynchronously growing cells (Figure 2b ). The observed differences in the effects of these two drugs on the induction of predominant forms of RNF8 might reflect differences in RNF8 regulates exit from mitosis V Plans et al their mechanisms of action, with nocodazole causing microtubule depolymerization and arrest before prometaphase, and taxol preventing depolymerization and inducing arrest in both G 2 and G 1 under certain conditions (Trielli et al., 1996) .
Overexpression of RNF8 causes accumulation of cells in G 1 and caspase-dependent apoptosis Green fluorescent protein forms of wild-type (GFP-RNF8 WT ) and RING-dead (GFP-RNF8
C403S
, devoid of ubiquitin ligase activity) RNF8 were transfected into HeLa cells, and the cell cycle distribution was analysed by flow cytometry at 28 and 33 h post transfection. Exogenous expression of GFP-RNF8
WT induced an increase in the G 1 population and a decrease in the S phase and G 2 -M populations relative to the control untransfected cells of the same experiment (Figures 3a  and b ). These effects were partially attenuated when the RING-dead mutant RNF8 C403S was transfected ( Figures  3a and b) . Most cells transfected with GFP-RNF8 WT showed a cytoplasmic staining for cyclin D1 (Figure 3c ). Cyclin D1 is expressed in the cytoplasm in early G 1 , translocates into the nucleus at late G 1 coincident with commitment to enter the S phase and exits the nucleus at the beginning of the S phase (Diehl et al., 1998) . Consequently, the association of GFP-RNF8-transfected cells with a cytoplasmic localization of cyclin D1 supported the conclusion that ectopic expression of RNF8 causes an accumulation in early G 1 . Conversely, the majority of RNF8-transfected cells did not stain for cyclin B1, in contrast to the abundant cells in the same fields in which nuclear cyclin B1 was associated with mitotic figures (Figure 3c ). Nuclear entry of cyclin B1 signals the initiation of mitosis (Pines and Hunter, 1991; Jin et al., 1998) , and its destruction signals exit from mitosis (Harper et al., 2002) . Therefore, the absence of detectable cyclin B1 in GFP-RNF8 transfected cells suggested that they are either in a post-mitotic phase or in early G 1 , before cyclin B1 accumulates in the cytoplasm.
Transfection of GFP-RNF8
WT also caused the appearance of a subpopulation of cells with a sub-G 1 DNA content that was more evident at later times after the transfection (Figure 3a) . This sub-G 1 population disappeared when cells were treated with the caspase inhibitor Z-VAD (not shown), indicating that overexpression of RNF8 induces caspase-dependent apoptosis in a subpopulation of cells. This conclusion was further supported by the induction of caspase-3 cleavage upon transfection of wild-type RNF8, an effect that was attenuated when cells were transfected with the RING-dead RNF8 variant ( Figure 3d ). WT and GFP-RNF C403S . Lysates from negative control (mock) or transfected cells were analysed by western blotting with an antibody specific for activated (cleaved) forms of caspase-3. As a positive control for activation of caspase-3, cells were treated for 24 h with 100 mM etoposide.
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Overexpression of RNF8 causes aberrant mitosis and unresolved cytokinesis Despite the accumulation of cells in G 1 in response to exogenous RNF8, the pattern of expression of endogenous RNF8 and its localization in the midbody of cells in cytokinesis ( Figure 2 ) suggested a role for RNF8 in the regulation of mitosis. We thus studied, at a singlecell level, the localization of transfected RNF8 and its effects on the progression of cells in mitosis.
When cells were transfected with GFP-RNF8 in the presence of the caspase inhibitor Z-VAD, the chimeric protein showed localizations that were not evident for the endogenous RNF8 protein. The most relevant new localizations under these conditions of overexpression of RNF8 were to normal and aberrant polar mitotic spindles (Figure 4a ). This was accompanied by the frequent observation of aberrant mitotic figures, seen in cells transfected with wild-type RNF8, but not with the RING-dead mutant RNF8
C403S
. Some aberrant figures consisted of three or more polar spindles, apparently originating from independent centrosomes, and associated with an abnormal distribution of condensed chromosomes (Figure 4a ). Remarkable aberrant figures were observed, with two adjacent midbodies containing GFP-RNF8, into which four separate bundles of microtubules converged from each of four cells (Figures  4a and b) . A proportion of RNF8-transfected and Z-VAD treated cells consisted of strings of 3-4 cells attached to each other by tubulin-containing mitotic bridges, with RNF8 localized at the midbodies ( Figures  4a and c) . In some instances, cells attached through mitotic bridges were clearly in different phases of the cell cycle, for example, with two attached cells in which nuclear division had been completed, suggestive of their being in G 1 or S, and a third attached cell in mitosis (Figure 4a , third column). This suggests that, in RNF8-transfected cells, mitotic bridges can form abnormally even with an ongoing metaphase or anaphase. Alternatively, it is possible that these multiple cell strings originated as a consequence of sequential cytokinesis before complete resolution of the first cytokinesis by abscission of the mitotic bridge. Thirty hours after the transfection of HeLa cells with GFP-RNF8
WT or with mutant GFP-RNF8 C403S , the proportion of mitotic cells in telophase was close to 80%, as compared to less than 45% in control cells. In cells transfected with GFP-RNF8
WT , approximately half of the cells in late telophase and attached by bridges corresponded to strings of three cells attached to each other through double mitotic bridges (Figure 4c ). The frequency of double mitotic bridges in cells transfected with the RING-dead mutant GFP-RNF8 C403S was reduced to approximately 20% of cells in late telophase, whereas no double bridges were found in control untransfected cells or cells transfected with GFP only (Figure 4c) .
The fact that these aberrant cells attached through multiple unresolved mitotic bridges were not seen under conditions in which cell death was not prevented suggests that such aberrant mitoses are not viable. This conclusion was supported by the appearance, without caspase inhibitors, of figures in which two RNF8-transfected cells were attached by a mitotic bridge, with one cell apparently viable, and the second cell with an apoptotic appearance (not shown).
Depletion of RNF8 delays mitotic exit after release from spindle assembly checkpoint activation The above experiments suggested a role for RNF8 in the rate of exit of cells from mitosis, in cytokinesis, or in WT or GFP-RNF8 C403S were stained for a-tubulin and DNA, and at least 100 GFP-positive cells were analysed for the appearance of mitotic structures that define each of the phases shown, that is, metaphase, anaphase or telophase, or the presence of mitotic bridges indicated by the convergence of tubulin-positive bundles in two or more cells clearly seen as attached under transmission mode.
RNF8 regulates exit from mitosis V Plans et al both processes. To further study the possible involvement of RNF8 in the regulation of mitotic exit, cells depleted of RNF8 by siRNA ( Figure 5a ) were subjected to treatment with nocodazole, followed by relief from this arrest by removal of the drug. Depletion of RNF8 did not cause any obvious effects on the basal cell cycle profiles of HeLa cells. Immediately after the release from the nocodazole-induced arrest, both control cells and cells depleted of RNF8 showed a marked increase in the G 2 -M population (Figures 5b-e) . After the removal of nocodazole, control siRNA-transfected cells recovered progressively from the arrest in G 2 -M, with only 37% of cells with a 4n DNA content 4 h after the release, and returned to a normally cycling-cell profile 6 h after the release from the arrest (Figures 5d and e) . In contrast, RNF8-depleted cells showed a clearly delayed capacity to exit from mitosis. Thus, 4 h after the removal of nocodazole, the G 2 -M population had not decreased in comparison with cells still under drug-induced arrest, and 6 h after the release, almost 50% of RNF8-depleted cells still had a 4n DNA content, as compared to 21.6% in control cells (Figures 5d and e) . In parallel experiments, the levels of cyclin B1 were determined by western blotting, under the same nocodazole arrest and release conditions as above. APC/C-targeted destruction of cyclin B1 signals the transition from metaphase into anaphase followed by completion and exit from mitosis (Harper et al., 2002) . Immediately after nocodazole treatment, the levels of cyclin B1 were elevated both in control and RNF8-depleted cells. In control cells, cyclin B1 levels clearly declined 4 h after the release from the nocodazole arrest (Figures 5b and c) . In contrast, the 
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V Plans et al decline in cyclin B1 levels in RNF8-depleted cells after their release from the nocodazole-induced arrest was clearly delayed relative to control cells (Figures 5b  and c ). These observations suggest that RNF8 is required for an efficient exit from mitosis.
Overexpression of RNF8 compromises spindle assembly checkpoint activation upon acute but not prolonged nocodazole treatment The delayed exit from mitosis after the activation of the spindle assembly checkpoint (SAC) by nocodazole observed in cells depleted of RNF8 led us to hypothesize that, in addition to a role in exit from mitosis, inappropriate expression of RNF8 might cause a deficient inactivation of SAC after recovery from microtubule depolymerization. The arrest of cells in metaphase caused by the activation of the SAC by nocodazole depends on the inactivation of the APC/C by recruitment of Mad2 and other checkpoint proteins to the kinetochores. After a brief treatment with nocodazole (0.5 mg ml À1 ), sufficient to activate the SAC (Figure 6a ; Howell et al., 2001) , control and mocktransfected HeLa cells exposed to nocodazole showed the expected translocation of Mad2 to the kinetochores (Figures 6b and d) . In contrast, cells overexpressing RNF8 showed a clearly diminished signal for Mad2 and a negligible localization of this checkpoint protein to kinetochores after nocodazole treatment (Figures 6b  and d) . This effect was attenuated in cells expressing the RING-dead mutant RNF8 C403S (Figures 6b and d) , suggesting again that this function requires the ubiquitin ligase activity of RNF8. The decrease in nocodazoleinduced localization of Mad2 to kinetochores by overexpression of RNF8 was not accompanied by changes in its abundance in asynchronous transfected cells (Figure 6c) .
RNF8 overexpression caused an accumulation of cells in G 1 , which could lead to difficulty in the analysis of the effects of RNF8 overexpression in subsequent checkpoints. Therefore, we studied the kinetics of the induction of the G 2 -M arrest by nocodazole and of accumulation in G 1 by expression of GFP-RNF8. Nocodazole alone (0.1 mg ml À1 ), as expected, caused a significant accumulation of cells with 4n DNA content, detectable as early as 3 h after the initiation of the treatment, with a gradual accumulation over time (Figure 7a ). By comparison, the kinetics of expression of transfected WT or GFP-RNF8 C403S . Between 16 and 12 metaphases were analysed by confocal microscopy for each condition. The asterisk denotes that the observed differences are statistically significant relative to the control (P ¼ 0.001).
RNF8 regulates exit from mitosis V Plans et al GFP-RNF8 and its effect on the cell cycle were delayed by several hours. The transfected protein was detectable by western blotting 6-9 h after transfection (time of addition of liposomic complexes) (Figure 7b, inset) , and accumulation in G 1 of the transfected cells was observable also after 9 h of transfection (Figure 7b) . From these experiments, we estimate that 18 h after transfection of GFP-RNF8, and 15 h of simultaneous treatment with nocodazole, approximately 50% of cells should accumulate in G 2 -M in the absence of a relief from the mitotic checkpoint activation.
To study if overexpression of RNF8 alleviates the block in mitosis caused by nocodazole, one might treat cells with the drug, followed by transfection of RNF8 and then determine the effects on the 4n population. Unfortunately, this experimental sequence yielded only marginal transfection efficiencies and massive cell death, even in the presence of caspase inhibitors, precluding data analysis (data not shown). Therefore, cells were first transfected with GFP-RNF8 and then incubated with nocodazole as early as 3 h after transfection, before any significant expression of GFP-RNF8 or cell cycle effects could occur. After 15 h of nocodazole treatment, cells were released, or not, from the mitotic block and collected, and the cell cycle distribution was analysed. These experiments were performed in the presence of the caspase inhibitor Z-VAD. As expected, mock-transfected cells were arrested at G 2 -M, with about 80% with a 4n DNA content (Figures 7c and d) . Although cells transfected with GFP-RNF8
WT showed a significantly reduced accumulation in the G 2 -M population after nocodazole treatment, with approximately 45% of the cells at the end of the 18-h treatment (Figure 7b ), this accumulation was not significantly different from the above-estimated accumulation in G 2 -M in the hypothesis of absence of relief from the mitotic block imposed by nocodazole.
Collectively, these observations suggest that overexpression of RNF8 causes both a block in G 1 and a compromise in spindle assembly checkpoint activation upon acute nocodazole treatment. In spite of the latter activity, overexpression of RNF8 does not affect the proportion of cells in G 2 -M after more prolonged nocodazole treatment, suggesting that additional mechanisms counteract at later times the effects of high levels of RNF8 on the localization of Mad2 to kinetochores upon activation of the spindle checkpoint.
Discussion
The ubiquitin ligase RNF8 is only one of two proteins in metazoans that combine an E2-recruiting RING-finger domain with a phosphopeptide recognition FHA ), in the presence of the caspase inhibitor Z-VAD (10 mM). The nocodazole treatment was initiated 3 h after the addition of liposomic complexes for the transfection of GFP-RNF8. Eighteen hours after the transfection, cells were harvested and the DNA content and cell cycle distribution of GFP-positive cells were analysed as mentioned above.
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V Plans et al domain. The other protein with this domain architecture is the mitotic regulator CHFR. Our observations show that both recognition motifs, and also the coiled-coil region adjacent to the RING-finger domain, are important for the constitutive nuclear localization of RNF8. The absence of any one of these domains leads to the frequent localization of the protein in the cytoplasm in interphase, which is never seen with the full-length wild-type protein, suggesting the existence of multiple nuclear localization functions on RNF8, possibly through interactions with other factors, since RNF8 does not contain recognizable conventional nuclear localization signals.
Additional observations made in this study indicate that RNF8 also plays a role in the cell cycle. Beginning in G 1 , RNF8 protein levels increased steadily until they reached a peak coincident with the highest proportion of cells in mitosis, followed by an abrupt decline in late mitosis. This pattern of expression suggests that either RNF8 has a critical function in mitosis, or its destruction in late mitosis is required for mitotic progression. However, two major consequences of the overexpression of RNF8 were to prevent progression from G 1 to S and also to cause caspase-3-dependent apoptosis. The arrest in G 1 -S, being of interest in its own right, led to difficulty in the study of the consequences of inappropriate expression of RNF8 in subsequent phases of the cell cycle. Therefore, we have resorted to experiments that permitted analyses at the single-cell level, in which the combination of morphology, the microtubule organization and the state of chromosome condensation were more informative in this respect than population-based flow cytometry. In this way, we were able to determine that ectopic expression of RNF8 caused a delay in the resolution of cytokinesis, accompanied with frequent aberrant mitoses and also prevented the localization of the checkpoint protein Mad2 to kinetochores as an early response to acute spindle assembly checkpoint activation by nocodazole. These activities required the ubiquitin ligase function of RNF8, since these effects were greatly attenuated if RING-dead mutants were expressed. A role for RNF8 in the regulation of mitotic exit was supported by release experiments after prolonged spindle assembly checkpoint activation by nocodazole, in which depletion of RNF8 also caused a reduced rate of exit from mitosis and a delayed recovery of cyclin B1 levels. Therefore, we have shown that the depletion of RNF8 can cause a delay in mitotic exit, while overexpression causes aberrant cytokinesis, suggesting that the levels of this protein must be tightly controlled for a normal, physiological progression in late mitosis. It has been proposed that the formation of multinucleate cells as a result of cytokinesis failure is an early event in tumor formation and underlies the subsequent development of genomic instability (Fujiwara et al., 2005; Shi and King, 2005) .
Thus, in spite of their structural similarities, RNF8 and CHFR regulate different cell cycle checkpoints. In mitosis, CHFR appears to delay metaphase entry by excluding cyclin B1 from the nucleus and ensure longterm cell survival upon spindle disruption (Scolnick and Halazonetis, 2000; Chaturvedi et al., 2002; Bothos et al., 2003) , whereas our observations suggest that RNF8 regulates late stages of mitosis. In the yeast Saccharomyces cerevisiae, two paralogous proteins, Dma1p and Dma2p, also bearing a FHA domain and a RING-finger domain, are negative regulators of the mitotic exit network under conditions of spindle position checkpoint activation (Fraschini et al., 2004) . The same study showed that overexpression of Dma2p causes defects in cytokinesis, with the induction of multinucleated cells with DNA contents higher than 2C (Fraschini et al., 2004) . Our observations suggest that, while Dma proteins in yeast delay mitotic exit in the presence of mispositioned spindles, RNF8 may be required for proper exit from mitosis after spindle checkpoint activation. On the other hand, overexpression of RNF8 causes cytokinesis defects in mammalian cells that are reminiscent of the effects of Dma2p overexpression in yeast cells.
In summary, RNF8 appears to exert several functions in the cell cycle, as a negative regulator of the G 1 -S transition, as necessary for efficient exit from mitosis and for proper resolution of cytokinesis. The inhibition by high levels of RNF8 of the localization of Mad2 to kinetochores in response to nocodazole suggests also a role in the regulation of the spindle assembly checkpoint, which deserves further investigation. Interestingly, both RNF8 and CHFR interact with the heterodimeric E2 enzyme UBC13-UEV Plans et al., 2006 ) that mediates Lys 63-based polyubiquitylation, which may suggest a role for this modification in mitotic transitions. A potential ubiquitin ligase activity of yeast Dma1p and Dma2p has not been characterized. It will be interesting to determine if RNF8, like CHFR (Mariatos et al., 2003; Satoh et al., 2003; Yu et al., 2005) , is dysregulated or functionally altered in human cancer.
Materials and methods
Expression plasmid constructs and site-directed mutagenesis Full-length HA-tagged RNF8 and its RING-dead C403S mutant were generated as described (Plans et al., 2006) . Constructs for the expression of partial fragments derived from RNF8 were generated by PCR using pcDNA-HA-RNF8 as a template, and cloned into pCMV-HA (Roche, Mannheim, Germany) or pEGFP (Clontech, Palo Alto, CA, USA). The RING-dead mutant pGFP-RNF8 C403S was generated by site-directed mutagenesis with the QuickChange procedure (Stratagene, La Jolla, CA, USA), using pGFP-RNF8 as the template.
Cell culture HeLa cells were grown in Dulbecco's modified Eagle's medium (DMEM) (PAA Laboratories, Linz, Austria) supplemented with 10% fetal bovine serum and antibiotics, penicillin (100 U ml
À1
) and streptomycin (100 mg ml À1 ), in an atmosphere of 5% CO 2 . For transfection, HeLa cells were seeded on Petri dishes or sterile glass coverslips at 60-80% confluence and transfected the following day with the appropriate circular plasmids with cationic liposomes (Lipofectamine, Invitrogen, Carlsbad, CA, USA) in Optimem Medium (Invitrogen) for 5 h. 
RNA interference
Small interference RNA duplexes were synthesized with the Silencer siRNA Construction Kit (Ambion, Austin, TX, USA). Two different target sequences were identified on the RNF8 mRNA corresponding to exon 3 (AAACATGAAGC CGTTATGAATCCTGTCTC) and exon 7 (AATGAGAACA ATTCGTCGTTCCCTGTCTC). A control siRNA duplex, with a 'scrambled' sequence was also designed and synthesized. Small interfering RNA duplexes were introduced into HeLa cells by two rounds of transfection with Lipofectamine (Invitrogen) at 48 h intervals and the specificity and efficacy of interference was assessed by western blotting and immunocytochemistry using a range of siRNA concentrations. For further experiments, the final concentration of siRNA duplexes was 50 nM.
Generation of antibodies
For the generation of RNF8-specific polyclonal antibodies, rabbits were immunized at 4-week intervals with a KLH-conjugated peptide corresponding to the sequence KNKELRTKRKC (positions 146 through 155 on RNF8) together with Freund's adjuvant. Rabbits were bled out and sera were retested for reactivity and specificity by ELISA and western blotting. The antibodies were purified by affinity chromatography on peptides immobilized on SulfoLink columns (Pierce, Rockford, IL, USA). The affinity-purified antibodies were further tested for reactivity and specificity by western blotting on extracts from cells transfected with the appropriate constructs, and by immunocytochemistry.
Western blotting
Cells were washed with PBS, lysed in lysis buffer (20 mM Tris-Cl, 0.5%. deoxycholate, 1% Triton X-100, 0.1% sodium dodecyl sulfate, 150 mM NaCl, 1 mM ethylenediamine tetra acetic acid) containing protease inhibitors (2 mg ml À1 aprotinin, 2 mg ml À1 leupeptin, 2 mg ml À1 pepstatin and 50 mg ml À1 phenylmethylsulfonyl fluoride) and quantitated. Equal amounts of protein per sample were dissolved in Laemmli sample buffer (100 mM dithiothreitol, 50 mM Tris-Cl pH 6.8, 2% sodium dodecyl sulfate, 0.1% bromophenol blue, 10% glycerol), boiled for 5 min, separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred electrophoretically onto polyvinylidene difluoride membranes for 60 min. Blots were washed, blocked with 5% defatted dry milk in TBST (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween-20) or PBST (135.1 mM NaCl, 2.7 mM KCl, 10.4 mM NaH 2 PO 4 , 1.8 mM KH 2 PO 4 , 0.1%Tween-20), incubated overnight with primary antibody diluted in blocking buffer at 4 1C with shaking, washed in TBST or PBST three times for 10 min and incubated for 1 h with horseradish peroxidase-conjugated secondary antibody diluted in blocking buffer. After final washes in TBST or PBST, reactivities were detected with a chemiluminescent substrate (Amersham, Uppsala, Sweden). For sample normalization, tubulin or actin content was determined by incubating the membranes with a mouse monoclonal anti-a-tubulin antibody (Sigma, St Louis, MO, USA; working concentration 4 mg ml À1 ) or a goat-anti-actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA; 2 mg ml activation, cells were treated with nocodazole at 0.1 or 0.5 mg ml À1 (Sigma) for 16 or 20 h, starting 5 h after transfection (for RNA-interfered cells, 5 h after the second transfection). Cells were released from the nocodazole arrest by washing away the drug and changing to fresh medium, and fixed for flow cytometry or lysed for western blotting at the indicated times.
